Article

Sustained epithelial interferon signaling modulates incomplete pathologic response in colorectal cancer

2025-03-26

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background & Aims</h4> Patients with colorectal cancer have heterogeneous clinical responses to chemotherapy, although clinical guidelines advise little variability in treatment selection based on molecular tumor features. Precision oncology research typically utilizes patient-derived tumor organoids (PDTO) to predict clinical outcomes, but such efforts are often not directed towards identi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0e0ff15b-db61-5b39-869e-f95f7f4a0921
DOI: 10.1101/2025.03.24.644737

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Sustained epithelial interferon signaling modulates incomplete pathologic response in colorectal cancerDOI 10.1101/2025.03.24.644737Read

Concurrent genetic and non-genetic resistance mechanisms to KRAS inhibition in CRCSemantic proximity Read

Single-Cell Transcriptomic Signatures Enable Stratified Combination Therapy for Platinum-Resistant Ovarian CancerSemantic proximity Read

Molecular Profiling of Exceptional Responders to Cancer Therapy.Semantic proximity Read

Trellis tree-based analysis reveals stromal regulation of patient-derived organoid drug responsesSemantic proximity Read

Targeting of TP53-independent cell cycle checkpoints overcomes FOLFOX resistance in Metastatic Colorectal CancerSemantic proximity Read

Clinical and genetic factors associated with tumor response to neoadjuvant (chemo)radiotherapy, survival and recurrence risk in rectal cancer.Semantic proximity Read

Organoids serve as viable <i>in vitro</i> model for functional precision medicine for mesonephric-like adenocarcinoma of the ovarySemantic proximity Read

Leveraging a Patient-Derived Tumoroid Platform for Precision Radiotherapy: Uncovering DNA Damage Repair Inhibitor-Mediated Radiosensitization and Therapeutic Resistance in Rectal CancerSemantic proximity Read

Integrated chromatin and transcriptomic profiling of patient-derived colon cancer organoids identifies personalized drug targets to overcome oxaliplatin resistanceSemantic proximity Read

Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancerSemantic proximity Read

SLFN11 captures cancer-immunity interactions associated with platinum sensitivity in ovarian cancerSemantic proximity Read

Dynamic alterations of genome and transcriptome in KRAS G13D mutant CRC PDX model treated with cetuximab.Semantic proximity Read